Trials / Conditions / Post-polycythemia Vera Myelofibrosis (Post-PV MF)
Post-polycythemia Vera Myelofibrosis (Post-PV MF)
7 registered clinical trials studyying Post-polycythemia Vera Myelofibrosis (Post-PV MF) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study of Pelabresib add-on to Ruxolitinib in Japanese Adult Patients With Myelofibrosis NCT07340138 | Novartis Pharmaceuticals | Phase 1 |
| Recruiting | MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People NCT07362225 | MPN Research Foundation | — |
| Unknown | Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis NCT04878003 | Kartos Therapeutics, Inc. | Phase 2 |
| Completed | Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis NCT04217993 | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Phase 2 |
| Terminated | Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib NCT03935555 | Samus Therapeutics, Inc. | Phase 1 |
| Active Not Recruiting | Extended Access of Momelotinib in Adults With Myelofibrosis NCT03441113 | GlaxoSmithKline | Phase 2 |